(3r)-1,7-diphenyl-(4e,6e)-4,6-heptadien-3-ol
- 1 lab in 1 country
- Funders: Thailand Science Research and Innovation and 1 more
- Cells1
Outcomes
3Stem cell differentiation
upin human cells1
1 study
Stem cell differentiation
upin human cells1
(3r)-1,7-diphenyl-(4e,6e)-4,6-heptadien-3-ol increases stem cell differentiation in human cells.
“DPHD promoted osteogenic differentiation, as shown by increased ALP activity, calcium deposition, and upregulation of osteogenic marker genes”
Cellsduring ex vivo expansion and differentiation2.5-5 μM
ACS omega18 May 2026
Senescence-associated secretory phenotype (SASP)
downin human cells1
1 study
Senescence-associated secretory phenotype (SASP)
downin human cells1
(3r)-1,7-diphenyl-(4e,6e)-4,6-heptadien-3-ol decreases senescence-associated secretory phenotype (SASP) in human cells.
“DPHD suppressed the secretion of cytokines associated with the Senescence-Associated Secretory Phenotype (SASP), including IL-1β, IL-6, and MCP-1”
Cells2.5-5 μM
ACS omega18 May 2026
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
(3r)-1,7-diphenyl-(4e,6e)-4,6-heptadien-3-ol decreases cellular senescence in human cells.
“DPHD significantly reduced senescence-associated β-galactosidase activity and reduced the expression levels of the cell cycle regulators p16 and p21”
Cells2.5-5 μM
ACS omega18 May 2026